Sale of TMR Business to Novadaq/Discontinued Operations

6 Months Ended

Jun. 30, 2012

Sale of TMR Business to Novadaq/Discontinued Operations

Sale of TMR Business to Novadaq/Discontinued Operations

10.Sale of TMR Business to Novadaq/Discontinued Operations

On November 5, 2010, the Company entered into an agreement to sell its TMR business to Novadaq. This transaction was approved by the Company’s shareholders at a special meeting on January 31, 2011 and the transaction closed on February 1, 2011.

Under terms of the agreement, Novadaq acquired substantially all of the Company’s assets that were used in the TMR business including all manufacturing rights, substantially all product inventories, and all equipment, intellectual property, regulatory approvals, clinical data and documentation related to TMR, for a purchase price of $1 million in cash and the assumption of all the Company’s obligations under service contracts as of the closing date totaling $614,000.  The total carrying value of the assets sold as of the transaction date was $385,000.  In addition, the Company incurred transaction costs of $50,000.  The Company has recorded a gain on sale of discontinued operations before income taxes of $1,179,000 in the statement of operations.

The operating results of these operations, including those related to the prior periods, have been reclassified from continuing operations to discontinued operations in the accompanying condensed consolidated financial statements.

Revenues and net income attributable to discontinued operations for the six months ended June 30, 2011 are as follows:

	Six months ended June 30 (In thousands)
	2011
Revenues:
Product sales	$	455
Service fees	68
Total	523
Income from discontinued operations	$	53